Booth Andrew · Chief Financial Officer at AbCellera Biologics Inc. · 47d agono track record yet
Long 37,200 shares of ABCL
Bought 37,200 @ $10.32 avg · $383,904 · 2026-08-14
Form 4: Booth Andrew bought ABCL
Booth Andrew (Chief Financial Officer at AbCellera Biologics Inc.) reported an open-market purchase of 37,200 shares of ABCL at an average $10.32, roughly $383,904, in a Form 4 filed 2026-08-14.
At post $11.38Now $12.63+11.0% since postedas of Sep 18, 4:30 PM ET
1d—
3d-1.6%
1w-0.5%
1m-4.3%
3m—
6m—
1y—